Published March 4th, 2019 in Nature Medicine, two new studies describe a combination approach to target the KRAS signaling pathway and a process called autophagy as a way to treat pancreatic cancer patients. Sources: Two Studies Point to New Combination Treatment for Pancreatic Cancer – Pancreatic Cancer Action Network, 3/4/2019 Advancements in Promising New Pancreatic … Continue reading Dr. Kirsten Bryant’s recent publication in Nature Medicine stimulates excitement for a new therapeutic strategy for pancreatic cancer.
Der Recognized at UNC-Syracuse Basketball Halftime
February 26, 2019 On Tuesday night, during the UNC-Syracuse game, Channing Der and other recipients of the 2019 Mentor Award for Lifetime Achievement, University of North Carolina at Chapel Hill lined up on the court to be recognized by the arena. Congratulations again, Channing!
Der Lab Berlin
Der Lab Berlin has been officially established at Charité, Universitätsmedizin Berlin in Germany. Charité was established in 1710 by King Frederick I of Prussia, in preparation for the bubonic plague. It was later used as a charity hospital for the poor and eventually integrated as a teaching hospital for Universitätsmedizin Berlin in 1828. It has … Continue reading Der Lab Berlin
Der to Receive Mentor Award from UNC-Chapel Hill
Channing Der, PhD, the Sarah Graham Kenan Distinguished Professor of Pharmacology and member of the UNC Lineberger Comprehensive Cancer Center, will receive the “Mentor Award for Lifetime Achievement” at an awards banquet April 8. All 24 recipients of University Teaching Awards will be recognized during halftime of the UNC men’s basketball game February 26. “These … Continue reading Der to Receive Mentor Award from UNC-Chapel Hill
Der Lab Par’bakes’ in a Cox Lab Tradition
The front room was crowded with lab members. Some hunched over a bench and others gingerly dodged with full trays between rooms. One lab member, gripping tweezers with the grace of a Venetian painter, dedicatedly arranged sprinkles on a rainbow-glazed sugar cookie. Take the energy of a family holiday dinner and the methodological focus of … Continue reading Der Lab Par’bakes’ in a Cox Lab Tradition
Tumor Targets Panel– Ruesch Center Annual Symposium 2018
https://www.youtube.com/watch?v=Nc-uE0Dzff0&feature=youtu.be Dr. John Marshall hosted a panel at the 2018 Ruesch Center Annual Symposium focused on tumor targets. Panel guests were Dr. Eric Collisson, Dr. Channing Der, and Dr. Michael Korn. Dr. Eric Collisson discusses the emergence in oncology of a new class of drugs called PARP inhibitors. These have been more commonly used in … Continue reading Tumor Targets Panel– Ruesch Center Annual Symposium 2018
UNC Lineberger Writes: Researchers identify resistance mechanism to possible pancreatic cancer treatment
In the journal Cancer Cell, UNC Lineberger's Channing Der, PhD, and colleagues described how pancreatic cancer may develop resistance to ERK inhibitors in pancreatic cancer. November 16, 2018 Despite decades of research, treatments that can target a common mutation in the most frequently diagnosed type of pancreatic cancer have remained elusive. Now, University of North … Continue reading UNC Lineberger Writes: Researchers identify resistance mechanism to possible pancreatic cancer treatment
UNC Lineberger Writes: Der receives NCI Outstanding Investigator Award
The National Cancer Institute’s Outstanding Investigator Award supports accomplished leaders in cancer research. November 13, 2018 UNC Lineberger’s Channing Der, PhD, has been awarded the National Cancer Institute’s Outstanding Investigator Award, which supports accomplished leaders in cancer research who are working on science with breakthrough potential. The award provides up to $600,000 in direct costs per … Continue reading UNC Lineberger Writes: Der receives NCI Outstanding Investigator Award
The Daily Tarheel Interviews Channing Der: “This UNC researcher studying pancreatic cancer just received a $600,000/year grant”
BY NATHAN WESLEY Channing Der, a UNC Lineberger Comprehensive Cancer Center member and Kenan Distinguished professor in the Department of Pharmacology, researches ways to decrease the rate of pancreatic cancer and introduce new therapies for patients. He recently received the National Cancer Institute Outstanding Investigator Award, given to researchers who study science with breakthrough potential, to advance his … Continue reading The Daily Tarheel Interviews Channing Der: “This UNC researcher studying pancreatic cancer just received a $600,000/year grant”
Channing Der Granted 2018 NCI Outstanding Investigator Award
The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research. The research funded will focus on exploiting novel protein kinases that regulate MYC protein stability to cause MYC loss, … Continue reading Channing Der Granted 2018 NCI Outstanding Investigator Award
Der Lab 